Summary

The MoldRx CIRS + Genetic Bundle is a specialized, clinician-guided testing solution designed for Canadians investigating Chronic Inflammatory Response Syndrome (CIRS). This bundle combines a blood-based CIRS biomarker panel (with clinician requisition) and an at-home HLA-DR genetic risk test (cheek swab), providing a comprehensive look at both current inflammatory status and genetic susceptibility to biotoxin-related illness. Results are delivered securely through a private portal, with clear, CIRS-informed interpretation and actionable next steps—always with a calm, evidence-cited approach. MoldRx’s workflow is built for Canadian regulations and logistics, with privacy-first handling and support for sharing results with your healthcare provider. This bundle is ideal for those on a CIRS recovery journey or anyone seeking structured, non-alarmist clarity about their health and environment.

Frequently Asked Questions
  • What is CIRS? * Chronic Inflammatory Response Syndrome (CIRS) is a condition involving a dysregulated immune response to biotoxins, often found in water-damaged buildings. Certain genetic factors, such as HLA-DR variants, may increase susceptibility. (View source)
  • How is the CIRS + Genetic Bundle different from the Complete + Genetic Bundle? * The CIRS + Genetic Bundle focuses on CIRS-specific biomarkers and genetic risk, providing targeted insight for those investigating or managing CIRS, whereas the Complete + Genetic Bundle covers a broader range of environmental and inflammatory markers.
  • Why test HLA-DR for CIRS? * Certain HLA-DR gene variants are associated with increased susceptibility to biotoxin illness and may impact how the immune system handles exposures. Testing helps clarify genetic risk as part of a CIRS assessment. (View source)
  • Do I need a CIRS diagnosis to order this bundle? * No formal diagnosis is required. The bundle is available to Canadians seeking clarity about possible CIRS, whether for initial investigation, ongoing monitoring, or to inform discussions with a CIRS-literate practitioner.
  • When will I receive my results? * Blood panel results are typically available within 7–10 business days after your lab draw; genetic results are delivered in 2–3 weeks. All results are accessible via a secure online portal.
References & Evidence
  • Chronic Inflammatory Response Syndrome: A Review of the Evidence of Clinical Efficacy of Treatment (Dooley M., Annals of Medicine and Surgery, 2024)
  • HLA Gene Variations and Mycotoxin Toxicity: Four Case Reports (Mycotoxin Research, 2024)
  • WHO Guidelines for Indoor Air Quality: Dampness and Mould (WHO, 2009)
  • Damp Indoor Spaces and Health (National Academies Press, 2004)
  • TGF-β Signaling in Health and Disease (Cell, 2023)
Medical Disclaimer:

The information provided is for educational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider regarding health concerns. MoldRx does not diagnose or treat medical conditions.

Start your CIRS + Genetic Bundle intake here
For more on MoldRx’s calm, Canadian-first approach, visit https://www.moldrx.com/